Drug development remains one of the most resource-intensive and failure-prone processes in healthcare. Traditional approaches depend heavily on trial-and-error ...
Continue reading
Natural history studies document disease progression by observing diseases in their unmodified state, deepening our understanding of how conditions evolve over ...
Continue reading
In this webinar, Sano’s Senior Project Manager Clare Clarke shares the approach Sano employs to achieve its mission of accelerating the world’s transition to pr...
Continue reading
Many hereditary diseases are clinically manageable when detected early, yet most carriers are identified only after symptoms appear. Population genomic screenin...
Continue reading
In this webinar, “Parkinson's disease: Engagement, screening, and retention," Sano CEO and Co-Founder Patrick Short shares a case study of Sano’s work on a gene...
Continue reading
Precision medicine represents a fundamental shift in how treatments are developed and delivered. Rather than relying on population-level assumptions about how p...
Continue reading
Over the last two decades, following the landmark achievement of sequencing the first complete human genome, a suite of powerful genetic tools has emerged. Gene...
Continue reading
Tissue engineering and regenerative medicine (TERM), integral to the evolution of precision medicine, are advancing methods to regenerate or repair damaged tiss...
Continue reading
Last year, Sano CEO Dr. Patrick Short presented a webinar called “Genetics Essentials for Clinical Research professionals.” In it, he explained the fundamentals...
Continue reading
Genomic screening is changing how clinicians and families approach prenatal and neonatal care. These tests, which analyze fetal or newborn DNA for chromosomal c...
Continue reading